Johnson & Johnson buy Traumtanz
Summary
This prediction ended on 06.08.24 with a price of €147.60. With a performance of -6.52%, the BUY prediction by Traumtanz finished with a loss. Dividends of €4.43 are taken into consideration when calculating the performance. Traumtanz has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Johnson & Johnson | 1.010% | 1.010% | -1.855% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to Traumtanz what are the pros and cons of Johnson & Johnson for the foreseeable future?
Pros
Cons
Comments by Traumtanz for this prediction
In the thread Johnson & Johnson diskutieren
In the thread Trading Johnson & Johnson
Stopped prediction by Traumtanz for Johnson & Johnson
Johnson & Johnson
24.07.23
24.07.24
16.08.23
Johnson & Johnson
11.07.23
11.07.24
24.07.23
Johnson & Johnson
26.09.22
26.09.23
11.07.23
Johnson & Johnson
21.11.20
10.12.20
Johnson & Johnson
29.04.20
30.04.20
30.04.20
Johnson & Johnson
26.03.20
20.04.20
20.04.20
Johnson & Johnson
10.03.20
20.03.20
20.03.20
Johnson & Johnson
17.07.19
19.07.19
19.07.19
Johnson & Johnson
17.07.19
17.07.19
17.07.19
Johnson & Johnson
11.12.18
17.12.18
17.12.18
Johnson & Johnson
25.07.17
23.03.18
23.03.18
Johnson & Johnson
28.01.17
24.07.17
24.07.17